- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02828085
Improvement of the Etiological Diagnosis of the Pericarditis (PERICARDITE)
April 20, 2023 updated by: Assistance Publique Hopitaux De Marseille
Pericardial syndrome includes pericardites acute pericardial effusion and cardiac tamponade, recurrent pericarditis squeezing chronic pericarditis.
The etiologies are very numerous and can be classified as infectious, neoplastic, metabolic or systemic, toxic causes.
Diagnosis is difficult, and 80% of etiologies remain classified idiopathic.
In their laboratory to improve the diagnosis of this syndrome investigators have developed a strategy of systematic prescription of biological tests by kit.
This prescription by 'kit' strategy proved its interest by comparison with an intuitive requirement of biological.
In this study investigators want to improve the diagnostic causative of pericarditis by implementing a new diagnostic strategy.
This new strategy includes (i) samples additional less invasive for the patient, the swab pharyngeal and nasal, (ii) the addition of at the outset of more effective diagnostic techniques: specific Polymerase Chain Reaction (PCR)
Study Overview
Study Type
Interventional
Enrollment (Actual)
979
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient prescribed with a pericarditis kit for etiological diagnosis of a pericardial syndrome.
- Adult patient (= or > 18 years old)
- Patient who freely signed the informed consent form.
- Patient affiliated to a health insurance regime
Exclusion Criteria:
- Minor patient ( age <18 years)
- Pregnant, parturient or breastfeeding woman
- Adult patient incapable or unable to consent
- Patient deprived of liberty under judgment
- Person living in a health or social specialised structure
- Person in vital emergency situation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Infective Pericarditis
In patient prescribed with a pericardite kit for an etiological diagnosis of a pericardial syndrome, an additional nasal swab will be performed in order to perform a specific diagnosis with PCR technique.
|
Nasal swab will be performed in addition to the routine diagnosis visit in order to determine the diagnosis of infective pericardite with a more specific technique: PCR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of pericarditis whose etiological diagnosis has been established.
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identification of the detected emerging pathogens among infectious causesof pericarditis
Time Frame: 1 day
|
1 day
|
Prevalence of the emerging pathogens: assessement of the percentage of emerging pathogens among the studied population
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2013
Primary Completion (Actual)
July 24, 2019
Study Completion (Actual)
October 26, 2022
Study Registration Dates
First Submitted
June 30, 2016
First Submitted That Met QC Criteria
July 6, 2016
First Posted (Estimate)
July 11, 2016
Study Record Updates
Last Update Posted (Actual)
April 21, 2023
Last Update Submitted That Met QC Criteria
April 20, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-30
- 2013-A00962-43 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infective Pericarditis
-
Mayo ClinicWithdrawn
-
Université de SherbrookeUnknown
-
Rabin Medical CenterTerminated
-
Virginia Commonwealth UniversityTerminated
-
Children's Healthcare of AtlantaTerminatedCongenital DisordersUnited States
-
Azienda Ospedaliero, Universitaria Ospedali RiunitiRecruitingRecurrent PericarditisItaly
-
R-Pharm Overseas, Inc.Data Management 365; Keystat, LLCNot yet recruitingRecurrent PericarditisUnited States
-
Hippocration General HospitalNot yet recruitingPericarditis Idiopathic RecurrentGreece
-
R-Pharm International, LLCR-Pharm; Unimed Laboratories CJSC; Data Management 365; Exacte Labs LLCActive, not recruitingIdiopathic Recurrent PericarditisRussian Federation
-
Cardiol Therapeutics Inc.Active, not recruitingRecurrent PericarditisUnited States
Clinical Trials on Nasal swab
-
University of Colorado, DenverGlaxoSmithKlineCompletedFever | Influenza | Otitis Media | Lower Resp Tract Infection | Encephalitic Infection | Myositis ViralUnited States
-
Rigshospitalet, DenmarkRecruitingCOVID-19 | Influenza | RSV InfectionDenmark
-
LumiraDx UK LimitedActive, not recruitingCOVID-19United States
-
Institut PasteurRecruiting
-
University Hospital, CaenCompletedMicrobial Colonization | Neonatal Infection | Viral InfectionFrance
-
Public Health EnglandCompletedImmunization; InfectionUnited Kingdom
-
University Hospital, CaenActive, not recruiting
-
Hospices Civils de LyonCompleted
-
Centre Hospitalier Universitaire de BesanconUnknownStaphylococcus Aureus Nasal CarriageFrance
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting